Sign in

You're signed outSign in or to get full access.

Nathan Trebek

Research Analyst at Wells Fargo

Nathan Trebek's questions to RESMED (RMD) leadership

Question · Q2 2026

Nathan Trebek asked if the strong U.S. mask strength, which saw 16% growth in fiscal Q2, is expected to persist at that level into the second half of the year.

Answer

CEO Mick Farrell acknowledged the 16% growth as an 'incredible performance' but noted that outperforming the high single-digit market growth by such a margin won't happen every quarter. He mentioned contributions from VirtuOx and successful promotional campaigns, stating the goal is to consistently meet or beat high single-digit mask growth.

Ask follow-up questions

Fintool

Fintool can predict RESMED logo RMD's earnings beat/miss a week before the call